Telerehabilitation Approaches in Chronic Obstructive Pulmonary Patients

Sponsor
Saglik Bilimleri Universitesi (Other)
Overall Status
Recruiting
CT.gov ID
NCT04694729
Collaborator
(none)
54
1
2
11
4.9

Study Details

Study Description

Brief Summary

Pulmonary rehabilitation (PR) is a first-line management strategy in chronic obstructive pulmonary patients (COPD) as it reduces shortness of breath, increases exercise capacity, and improves health-related quality of life. However, 8-50% of patients referred to PR do not participate at all, while 10-32% of those who start do not complete the program. Barriers to participation and completion include difficulty in accessing the program, poor mobility, lack of transport, and travel costs. Telerehabilitation is defined as the provision of rehabilitation services through telecommunication technology, including telephone, internet and video conference communications between the patient and the healthcare provider. Different technologies (from phone to video conferencing) have been tested in patients with COPD to enhance daily activities, exercise training and walking prescription. All of them showed positive effects on exercise tolerance, dyspnea, physical activity and quality of life. However, there is no study about which telerehabilitation program is more effective on COPD patients. The aim of this study is to investigate which telerehabilitation approach is more effective in COPD.

Condition or Disease Intervention/Treatment Phase
  • Other: videoconference-based
  • Other: video-based
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of the Effectiveness of Different Telerehabilitation Approaches in Chronic Obstructive Pulmonary Patients
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Mar 1, 2021
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: study group

Videoconference-based

Other: videoconference-based
Exercises will be done 3 days a week for 6 weeks, with the help of a physiotherapist via video conference.

Experimental: control group

Video-based

Other: video-based
The exercise video will be sent to the patients and they will do it 3 days a week for 6 weeks. The subjects will be asked to keep an exercise diary and the status of the diaries will be followed by calling once a week.

Outcome Measures

Primary Outcome Measures

  1. 6 minute walk test(6MWT) [6 week]

  2. Pulmonary function testing [6 week]

Secondary Outcome Measures

  1. 30-Second Chair Stand Test [6 week]

  2. Time Up and Go Test [6 week]

  3. Copd Assessment Test [6 week]

  4. St George's Respiratory Questionnaire [6 week]

  5. Hospital Anxiety and Depression Scale [6 week]

  6. Medical Research Council Scale [6 week]

  7. Short Physical Performance Battery [6 week]

  8. International Physical Activity Questionnaire-Short Form [6 week]

  9. Static Lung Volumes [6 week]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being diagnosed with COPD (FEV1 / FVC <70% in the stable phase of the disease)

  • Age > 18 years old

  • Have the ability to use a smartphone

Exclusion Criteria:
  • Musculoskeletal disorders that limit exercise

  • Dizziness, significant sensory or motor impairments, dementia or terminal illnesses that prevent education

  • Serious comorbidities such as unstable heart disease, irregular diabetes, known malignant disease, any other disease that makes the patient unsuitable for participation in the study.

  • Incompatible patient

  • Severe vision or hearing impairment

  • Unwillingness or inability to follow the protocol

  • Have had a COPD exacerbation in the previous 6 weeks

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital Istanbul Turkey

Sponsors and Collaborators

  • Saglik Bilimleri Universitesi

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nursima Bulut, Physiotherapist, Saglik Bilimleri Universitesi
ClinicalTrials.gov Identifier:
NCT04694729
Other Study ID Numbers:
  • TeleCOPD
First Posted:
Jan 5, 2021
Last Update Posted:
Jan 6, 2021
Last Verified:
Jan 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 6, 2021